HealthQuill weight loss
The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic adults with obesity, according to a statement from the EU regulator.
Drugs Health Pharma

Wegovy gets EU regulator backing on lowering heart risks in obese people

The European Medicines Agency has backed Novo Nordisk’s Wegovy to expand the weight-loss drug’s application to lower heart risks and strokes in non-diabetic.

Read More
The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering from heart problems or stroke.
Drugs Health Pharma

Novo Nordisk’s Wegovy gets UK regulator nod to treat heart risks

The UK’s Medicines and Healthcare products Regulatory Agency has approved Novo Nordisk’s weight-loss drug to cut the risk of obesity and adults suffering.

Read More
US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side effects.
Drugs Health Pharma

Viking Therapeutics’ weight-loss drug shows ‘positive’ results in early trials

US-based biotechnology company Viking Therapeutics Inc., reported “positive” results from its early-stage weight-loss oral drug and the pill showed mild to moderate side.

Read More
Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company announced.
Drugs Health Pharma

Novo Nordisk unveils new drug to fight obesity, says 13% effective

HQ Team March 11, 2024: Danish drugmaker Novo Nordisk’s oral medicine, amycretin, for obesity can cause up to 13% weight loss, the company.

Read More
Diabetes drugs used in weight-loss therapies may come with a risk of stomach paralysis, pancreatitis and bowel obstruction, a study by the University of British Columbia found.
Drugs Health Medical

Study finds unexpected link between weight loss and cancer risk

HQ Team March 4, 2024: Obesity is widely recognized as a risk factor for cancer, and a recent study sheds light on an.

Read More
Eli Lilly’s weight-loss injection Zepbound, taken along as a supplement with diet and exercise, got the USFDA and UK regulator’s nod after clinical trials proved adults lost 48 pounds on average during treatment.
Drugs Health Pharma

US, UK regulators give green light to Eli Lilly’s weight-loss treatment

HQ Team November 9, 2023: Eli Lilly’s weight-loss injection Zepbound, to be taken along as a supplement with diet and exercise, got the.

Read More
A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the University of Florida
Drugs Health Pharma

Weight-loss drug mimicking exercise may help treat obesity, diabetes

HQ Team October 2, 2023: A drug that mimics the benefits of rigorous exercise has been developed on mice by scientists at the.

Read More
Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s   ‘no action required’ classification for its domestic facility in the country’s south.
Drugs Health Pharma Uncategorized

India’s Lupin unveils thiamine injection in US, receives FDA’s NAR for Vizag unit

HQ Team June 20, 2023: Indian pharmaceutical company, Lupin Limited, has introduced its thiamine injection in the US market and has got FDA’s.

Read More
Diabetes
Drugs Health Medical

Oral semaglutide reduces HbA1c, weight in Type 2 diabetics, study reveals

HQ Team June 8, 2023: A new study analyzing the PIONEER (Peptide Innovation for Early Diabetes Treatment) clinical trials data has revealed the.

Read More
The use of non-sugar sweeteners leads to an increased risk of type 2 diabetes, cardiovascular diseases, and mortality in adults in the long term, according to the World Health Organization.
Drugs Health Pharma

WHO advises against use of non-sugar sweeteners for weight loss, NCDs

HQ Team May 15, 2023: The use of non-sugar sweeteners leads to an increased risk of type 2 diabetes, cardiovascular diseases, and mortality.

Read More
X